In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 74 for your search:
Drug:  decitabine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR017842, DACOGENMDS4013, Long-term treatment of Dacogen, NCT01400633

2.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0358, NCT00398983

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUPERGEN-D-0007, ABCCC-010303, NCT00043381

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: CDR0000256224, EORTC-06011, SUPERGEN-EORTC-06011, GMDSG-EORTC-06011, EudraCT-2005-002830, NCT00043134

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 65 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DACO-016, NCT00260832

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR015037, DACOGENMYE3001, NCT01026376

7.

Phase: Phase III
Type: Natural history/Epidemiology
Status: Completed
Age: 20 to 70
Sponsor: Other
Protocol IDs: H-1012-015-342, NCT01409070

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 15 to 55
Sponsor: NCI, Other
Protocol IDs: DM94-064, P30CA016672, MDA-DM-94064, NCI-G96-0999, CDR0000065033, NCT00002831

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 60 and under
Sponsor: NCI, Other
Protocol IDs: DM94-077, P30CA016672, MDA-DM-94077, NCI-G96-1000, CDR0000065034, NCT00002832

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 06-054, MSKCC-06054, NCT00382200

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 0704-07 IUCRO-0185, NCT00477386

12.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UPCI 07-008, NCT00715793

13.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: 08-0172 / 201012979, NCT00691938

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-0450, NCT00791271

15.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CASE2908, NCI-2010-00135, NCT01165996

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 70 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CYC682-11, NCT01211457

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: NCI-94-C-0002A, NCI-CPB-332

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MSKCC-98017, NCI-G98-1444, NCT00003361

19.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: EORTC-55857

20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: EORTC-16851C

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: EORTC-20861

22.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: EORTC-16851G

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-30871

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 14 to 70
Sponsor:
Protocol IDs: EORTC-06893

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-02516, MDA-ID-02205, N01CM62202, CDR0000270678, NCI-5737, 5737, NCT00054431
1    
New Search